Sixth International Conference on Cell Therapy for Cardiovascular Disease (IC3D)
|Event Date/Time: Jan 20, 2011||End Date/Time: Jan 21, 2011|
|Registration Date: Jan 20, 2011|
|Early Registration Date: Dec 17, 2010|
Now in its 10th year of clinical trials, the application of stem cells in the treatment of cardiovascular diseases has seen many notable successes, as well as identified challenges that await the next round of clinical studies.
The program will be dedicated to the evolving field of cell-based therapies for the repair and regeneration of cardiac and vascular disease, as well as related diseases such as diabetes and stroke. This yearâ€™s conference will focus on commercialization aspects of the field, highlighting the status of molecular, cell, and tissue products in addition to delivery systems.
Leaders from the international community of will convene to present their work, experiences, observations, and opinions on the benefits and unmet challenges of cell-based therapies.
The overall format for IC3D 2011 has changed to emphasize products and their development.
Day 1: The Widening Biologic Spectrum will focus on clinical trials, basic and molecular strategies and commercial development of:
Autologous cell products
Allogeneic cells, hybrid preparations, and specialty products
Molecular interventions: Macro and micro Agents
Day 2: Stem Cell Voyages: Pathways to Success in Cardiovascular Diseases
Delivery methods and imaging
Selection of biologics and methodologies in the development of the next generation of clinical trials